MID-LAND CHEMICALS (2003) LTD. - Որոնման արդյունքները

Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

lenalidomide mylan

mylan ireland limited - lenalidomid - multippelt myelom - immunsuppressive - multiple myelomalenalidomide mylan as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide mylan as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for transplant. lenalidomide mylan in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide mylan in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1-3a).

Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

arimidex 1 mg

laboratoires juvisé pharmaceuticals - anastrozol - tablett, filmdrasjert - 1 mg

Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

arimidex 1 mg